Abstract
Mesenchymal stromal cells (MSCs) and induced pluripotent stem cells (iPSCs) have stimulated much interest in the scientific community and hopes among the general public since their discovery in 1966 due to a variety of potential applications it has in the field of regenerative medicine. Copious amount of literature, as well as long-term animal and human clinical trials, indicates that MSCs can be successfully used for therapeutic purpose without any extreme adversities. MSCs have been isolated from adult and fetal tissues. Recently, MSCs from placenta have generated much inquisitiveness. In this article, we will demonstrate the step-by-step procedure for isolating human placental MSCs from term placenta, reprogramming of placental MSCs into iPSCs using plasmid vectors, evaluation of functional recovery in mice spinal cord injury models, and in vivo tracking of the transplanted cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sabapathy V, Tharion G, Kumar S (2015) Cell therapy augments functional recovery subsequent to spinal cord injury under experimental conditions. Stem Cells Int 2015:1–12
Friedenstein AJ, Deriglasova UF, Kulagina NN et al (1974) Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2:83–92
Sabapathy V, Ravi S, Srivastava V et al (2012) Long-term cultured human term placenta-derived mesenchymal stem cells of maternal origin displays plasticity. Stem Cells Int 2012:1–11
Sabapathy V, Sundaram B, Vm S et al (2014) Human Wharton’s jelly mesenchymal stem cells plasticity augments scar-free skin wound healing with hair growth. PLoS One 9:e93726
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676
Takahashi K, Tanabe K, Ohnuki M et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872
Yamanaka S (2012) Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 10:678–684
Sabapathy V, Mentam J, Jacob PM et al (2015) Noninvasive optical imaging and in vivo cell tracking of indocyanine green labeled human stem cells transplanted at superficial or in-depth tissue of SCID mice. Stem Cell Int 2015:1–8
Papapetrou EP, Lee G, Malani N et al (2011) Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells. Nat Biotechnol 29:73–78
Acknowledgments
We are grateful to Department of Biotechnology (DBT), Government of India for Ramalingaswami Fellowship and research support grants (DBT Grants BT/PR8527/MED/31/234/2013; BT/PR8742/AGR/36/773/2013; and BT/PR 15420/MED/31/122/2011) to Sanjay Kumar. We acknowledge and thank Indian Council of Medical Research (ICMR) for Junior/Senior Research Fellowship(s) to Franklin Jebaraj Herbert. We would like to thank Dr. Anne George Cherian, Department of Obstetrics & Gynaecology and Dr. George Tharion, Department of Physical Medicine & Rehabilitation for valuable assistance during research.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Sabapathy, V., Herbert, F.J., Kumar, S. (2017). Therapeutic Application of Placental Mesenchymal Stem Cells Reprogrammed Neurospheres in Spinal Cord Injury of SCID. In: Di Nardo, P., Dhingra, S., Singla, D. (eds) Adult Stem Cells. Methods in Molecular Biology, vol 1553. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6756-8_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6756-8_8
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6754-4
Online ISBN: 978-1-4939-6756-8
eBook Packages: Springer Protocols